Danielle J. Yoesep

[Danielle J. Yoesep @djyoesep]

@jareddashevsky You're looking for @_HonaAI's offering! Templatized summary of your patients' charts holding the info you deem pertinent. Primary sources linked, exactly how you've noted. Working on integration with Epic if you'd like to chat!

[Danielle J. Yoesep @djyoesep]

@jareddashevsky @_HonaAI Would be great to chat if you’re interested!

[Danielle J. Yoesep @djyoesep]

@jareddashevsky This is exactly the problem @_HonaAI is trying to address! Have our AI sift through and organize your patients’ records into a concise report with all the info you deem pertinent. https://t.co/FryomPTgzb

[Danielle J. Yoesep @djyoesep]

@beeaachbabe Can I read it

[Danielle J. Yoesep @djyoesep]

@nic_detommaso 👋🏼 Hello and thank you!

[Drew Oetting @andrewoetting]

Really excited about Swiftscale and Resilience coming together. Swiftscale’s world class cell-free protein synthesis tech combined with the Resilience’s advanced manufacturing infra will be game changing for increasing speed of getting next-gen therapies to patients!

[Robert Nelsen @rtnarch]

Resilience continues to build its unique technology base with acquisition of SwiftScale.

[Ryan Flinn @RS_Flinn]

Super cool technology - eliminates the need for live cells in drug productions, speeding development time from weeks to hours. Could have a huge impact on the biopharma industry. Will be promoting this a lot more in 2022.

[Resilience @IncResilience]

News: we acquired SwiftScale Biologics, a leader in cell-free protein synthesis, a biomanufacturing process that can produce drugs faster with greater scalability. This technology is a promising avenue to produce next-generation therapies -- read more: https://t.co/qRv83smNM1

[CellFree Sciences @CFSciences]

#SARSCoV2 development of treatment by @jewettlab_NU et al.: #openaccess

Multivalent designed proteins protect against SARS-CoV-2 variants of concern https://t.co/Z79Eg5PzVM

[Cole Kmet @ColeKmet]

I literally could be playing in my backyard….

[Adam Sandler @AdamSandler]

Happy loves you all! Thanks for everything!

[Robert Kroese @robkroese]

The SEC about to ban outsider trading

[Mark Lazerus @MarkLazerus]

Joel Quenneville: "Dunc's gotta get a haircut."

[Vishaal B. Bhuyan @VishaalBhuyan]

This is incredibly cool with 85% efficiency..the battery is charged when the tower it stacked. I love new takes on simple science...

SoftBank bets on Energy Vault to store energy in concrete blocks — Quartz https://t.co/RUP4nVPyPZ

[ダルビッシュ有(Yu Darvish) @faridyu]

😂

[Michael C. Jewett @MichaelCJewett]

New paper from the group by @mjhammerling @djyoesep. We developed a process for RT-PCR of full-length ribosomal RNA that can be used for #ribosome engineering, and also studying long RNAs. @NUSynBio

https://t.co/ti2M9WnaGe

[Melanie Matheu, PhD @melanie_matheu]

@nonstandardcode @sethbannon @fiftyyears Those guys are great for production. Can't wait to see them grow. @SwiftScaleBio

[Seth Bannon @sethbannon]

It's beyond time to moved past animal-derived antibody production. It's slow, expensive, and cruel.

Would love to support a team building in vitro technologies for antibody generation.

Who's working on this?

https://t.co/GAU6VuqJLS

[Jesse Rogers @JesseRogersESPN]

Kyle Schwarber says Kyle Hendricks won't have a fast heartbeat when he takes the ball: "He might not smile. He might not frown either."